Characterization of potential predictive biomarkers of response to nivolumab in CheckMate-141 in patients with squamous cell carcinoma of the head and neck (SCCHN). Ferris, R. L., Concha-Benavente, F., Blumenschein, G. R., Harrington, K. J., Fayette, J., Colevas, A., Licitra, L. F., Kasper, S., Even, C., Gillison, M. L., Worden, F., Saba, N. F., Haddad, R. I., Tahara, M., Hasegawa, Y., Yen, C., Lynch, M., Monga, M., Geese, W. J., Vokes, E. E. AMER SOC CLINICAL ONCOLOGY. 2017

View details for Web of Science ID 000443282900006